Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Clinical Pain 2021; 20(2): 99-104
Published online December 31, 2021 https://doi.org/10.35827/cp.2021.20.2.99
Copyright © Korean Association of Pain Medicine.
Mi Kyung Cho, M.D., Dong Min Kim, M.D., Young Mo Kim, M.D., Tae-Woong Yang, M.D., Jin-A Yoon, Ph.D. and Byeong-Ju Lee, M.D.
조미경ㆍ김동민ㆍ김영모ㆍ양태웅ㆍ윤진아ㆍ이병주
Objective: To confirm the safety of Intra-articular (IA) injection on the ipsilateral adhesive capsulitis (AC) after breast cancer surgery. Methods: Between January 2017 and May 2020, we retrospectively studied 29 patients after breast cancer surgery who underwent IA injection in the glenohumeral joint for AC in aseptic procedure. Results: There were no side effects or complications such as lymphedema or cellulitis in the patients. There was a significant improvement in pain score and range of motion (ROM) at the 1st, 3rd, and 6th months visits compared to the baseline (p<0.05). The presence or absence of axillary lymph node dissection and radiation therapy had no significant difference in improvement of ROM. But, in rotator cuff syndrome (RCS) group, there was a significant difference in improvement of shoulder IR in patients without RCS. Conclusion: IA Injection on the ipsilateral AC after breast cancer surgery was safe and even effective to improve pain and shoulder ROM. Ipsilateral IA injection can be a good treatment for breast cancer surgery patients suffering from AC.
KeywordsAdhesive capsulitis, Breast cancer, Frozen shoulder, Intraarticular injection, Lymphedema